144 related articles for article (PubMed ID: 9513950)
1. Review, reevaluation, and new results in quantitative structure-activity studies of anticonvulsants.
Hadjipavlou-Litina D
Med Res Rev; 1998 Mar; 18(2):91-119. PubMed ID: 9513950
[TBL] [Abstract][Full Text] [Related]
2. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
3. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR design of novel antiepileptic sulfamides.
Gavernet L; Dominguez Cabrera MJ; Bruno-Blanch LE; Estiú GL
Bioorg Med Chem; 2007 Feb; 15(3):1556-67. PubMed ID: 17158052
[TBL] [Abstract][Full Text] [Related]
6. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure activity relationships (QSAR) of substituded (S)-phenylpiperidines as preferential dopamine autoreceptor antagonists.
Pontiki EA; Hadjipavlou-Litina DJ; Demertzis AM; Hadjidakis I; Kovala-Demertzi D
J Enzyme Inhib Med Chem; 2005 Feb; 20(1):5-12. PubMed ID: 15895678
[TBL] [Abstract][Full Text] [Related]
8. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
[TBL] [Abstract][Full Text] [Related]
9. 2D and 3D QSAR analysis of some valproic acid metabolites and analogues as anticonvulsant agents.
Netzeva T; Doytchinova I; Natcheva R
Pharm Res; 2000 Jun; 17(6):727-32. PubMed ID: 10955848
[TBL] [Abstract][Full Text] [Related]
10. Can we develop improved derivatives of valproic acid?
Bialer M; Haj-Yehia A; Badir K; Hadad S
Pharm World Sci; 1994 Feb; 16(1):2-6. PubMed ID: 8156045
[TBL] [Abstract][Full Text] [Related]
11. Chalcones in cancer: understanding their role in terms of QSAR.
Katsori AM; Hadjipavlou-Litina D
Curr Med Chem; 2009; 16(9):1062-81. PubMed ID: 19275612
[TBL] [Abstract][Full Text] [Related]
12. Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2004 Nov; 24(6):687-747. PubMed ID: 15250038
[TBL] [Abstract][Full Text] [Related]
13. A quantitative structure-activity relationship (QSAR) analysis of the effects of aromatic substitution on the anticonvulsant activity and toxicity of arylsuccinimides.
Lange J; Kaźmierski W; Daroszewski J
Pol J Pharmacol Pharm; 1991; 43(1):71-7. PubMed ID: 1771166
[TBL] [Abstract][Full Text] [Related]
14. The importance of triazole scaffold in the development of anticonvulsant agents.
Ayati A; Emami S; Foroumadi A
Eur J Med Chem; 2016 Feb; 109():380-92. PubMed ID: 26826582
[TBL] [Abstract][Full Text] [Related]
15. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
[TBL] [Abstract][Full Text] [Related]
16. Applications of genetic algorithms on the structure-activity relationship analysis of some cinnamamides.
Hou TJ; Wang JM; Liao N; Xu XJ
J Chem Inf Comput Sci; 1999; 39(5):775-81. PubMed ID: 10529984
[TBL] [Abstract][Full Text] [Related]
17. Carboxylate bioisosteres of pregabalin.
Schwarz JB; Colbry NL; Zhu Z; Nichelson B; Barta NS; Lin K; Hudack RA; Gibbons SE; Galatsis P; DeOrazio RJ; Manning DD; Vartanian MG; Kinsora JJ; Lotarski SM; Li Z; Dickerson MR; El-Kattan A; Thorpe AJ; Donevan SD; Taylor CP; Wustrow DJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3559-63. PubMed ID: 16621528
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents.
Bryans JS; Davies N; Gee NS; Dissanayake VU; Ratcliffe GS; Horwell DC; Kneen CO; Morrell AI; Oles RJ; O'Toole JC; Perkins GM; Singh L; Suman-Chauhan N; O'Neill JA
J Med Chem; 1998 May; 41(11):1838-45. PubMed ID: 9599234
[TBL] [Abstract][Full Text] [Related]
19. 3D QSAR studies on 1, 3, 4-thiadiazole derivatives: an approach to design novel anticonvulsants.
Thareja S; Aggarwal S; Verma A; Bhardwaj TR; Kumar M
Med Chem; 2010 Jul; 6(4):233-8. PubMed ID: 20843285
[TBL] [Abstract][Full Text] [Related]
20. A computational quantitative structure-activity relationship study of carbamate anticonvulsants using quantum pharmacological methods.
Knight JL; Weaver DF
Seizure; 1998 Oct; 7(5):347-54. PubMed ID: 9808108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
